Ricevi le ultime notizie sulle azioni NeuroPace con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di NPCE

Ultime notizie per

NEUROPACE INC

NeuroPace

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

NeuroPace Inc

News

Management

Press Releases

NeuroPace Announces Strategic CFO Transition

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE

Legal

NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025

Health Care

NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases

Earnings

NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

NeuroPace to Participate in Upcoming Healthcare Conferences

NPCE

AngioDynamics

BrainsWay Ltd. - American Depositary Shares

BrainsWay

Carlsmed

CeriBell

CapsoVision

CVRx

Delcath Systems

Alpha Tau Medical

Electromed

Inogen

Monogram Technologies Inc. - Common Stock

Monogram Technologies

Nyxoah

Outset Medical

Senseonics Holdings

Shoulder Innovations

Semler Scientific

SANUWAVE Health

Surmodics

Streamex

Stereotaxis

Tactile Systems Technology, Inc. - Common Stock

Tactile Systems Tech

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts

USBC

Varex Imaging

ZimVie

Wells Fargo

HC Wainwright & Co.

JP Morgan

Cantor Fitzgerald

Comments

NeuroPace Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO